Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  15 نتائج ل ""Clinical Trials, Phase III as Topic""

فلترة النتائج

Publication : scientific reports
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Comparative overall survival of CDK4/6 inhibitors in combination with endocrine therapy in advanced breast cancer.

  • Authors : Kappel C; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.; Elliott MJ

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy; Female

  • Source: Scientific reports [Sci Rep] 2024 Feb 07; Vol. 14 (1), pp. 3129. Date of Electronic Publication: 2024 Feb 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Application of statistical machine learning in biomarker selection.

  • Authors : Vashistha R; Department of Statistics and Data Sciences, The University of Texas at Austin, Austin, TX, USA.; Noor Z

Subjects: Machine Learning*; Humans ; Bayes Theorem

  • Source: Scientific reports [Sci Rep] 2023 Oct 26; Vol. 13 (1), pp. 18331. Date of Electronic Publication: 2023 Oct 26.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The incidence of COVID-19 infection following emergency use authorization of BBIBP-CORV inactivated vaccine in frontline workers in the United Arab Emirates.

Subjects: COVID-19/COVID-19/COVID-19/*diagnosis ; COVID-19 Vaccines/COVID-19 Vaccines/COVID-19 Vaccines/*administration & dosage ; Vaccines, Inactivated/Vaccines, Inactivated/Vaccines, Inactivated/*administration & dosage

  • Source: Scientific reports [Sci Rep] 2022 Jan 11; Vol. 12 (1), pp. 490. Date of Electronic Publication: 2022 Jan 11.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Efficacy, safety and tolerability of drugs studied in phase 3 randomized controlled trials in solid tumors over the last decade.

  • Authors : Ribnikar D; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.; Division of Medical Oncology and Hematology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, 700U, 7-721, Toronto, ON, M5G 2M9, Canada.

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Neoplasms/Neoplasms/Neoplasms/*drug therapy; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/adverse effects

  • Source: Scientific reports [Sci Rep] 2021 May 25; Vol. 11 (1), pp. 10843. Date of Electronic Publication: 2021 May 25.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis.

  • Authors : O'Shaughnessy J; Baylor University Medical Center, Texas Oncology and US Oncology, Dallas, TX, USA. .; Cortes J

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy ; Furans/Furans/Furans/*therapeutic use

  • Source: Scientific reports [Sci Rep] 2020 Jul 08; Vol. 10 (1), pp. 11203. Date of Electronic Publication: 2020 Jul 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients.

  • Authors : Podlaha O; Gilead Sciences Inc., 333 Lakeside Drive, Foster City, CA, 94404, USA. .; Gane E

Subjects: Genome, Viral*; Hepatitis B e Antigens/Hepatitis B e Antigens/Hepatitis B e Antigens/*genetics ; Hepatitis B virus/Hepatitis B virus/Hepatitis B virus/*genetics

  • Source: Scientific reports [Sci Rep] 2019 Jul 19; Vol. 9 (1), pp. 10529. Date of Electronic Publication: 2019 Jul 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×

The incidence of COVID-19 infection following emergency use authorization of BBIBP-CORV inactivated vaccine in frontline workers in the United Arab Emirates

Subjects: Adult; Male; COVID-19 Vaccines

  • Source: Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)Scientific Reports

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

PD-1 inhibitors increase the incidence and risk of pneumonitis in cancer patients in a dose-independent manner: a meta-analysis.

  • Authors : Wu J; The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.; Hong D

Subjects: Pneumonia*/Pneumonia*/Pneumonia*/chemically induced ; Pneumonia*/Pneumonia*/Pneumonia*/epidemiology; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*adverse effects

  • Source: Scientific reports [Sci Rep] 2017 Mar 08; Vol. 7, pp. 44173. Date of Electronic Publication: 2017 Mar 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A novel pleuromutilin antibacterial compound, its binding mode and selectivity mechanism.

  • Authors : Eyal Z; Department of Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.; Matzov D

Subjects: Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/chemistry ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacology ; Ribosome Subunits, Large, Bacterial*/Ribosome Subunits, Large, Bacterial*/Ribosome Subunits, Large, Bacterial*/chemistry

  • Source: Scientific reports [Sci Rep] 2016 Dec 13; Vol. 6, pp. 39004. Date of Electronic Publication: 2016 Dec 13.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Comparative analysis of pentavalent rotavirus vaccine strains and G8 rotaviruses identified during vaccine trial in Africa.

  • Authors : Heylen E; KU Leuven - University of Leuven, Department of Microbiology and Immunology, Laboratory for Clinical and Epidemiological virology, Rega Institute for Medical Research, Leuven, Belgium.; Zeller M

Subjects: Rotavirus/Rotavirus/Rotavirus/*isolation & purification ; Rotavirus Infections/Rotavirus Infections/Rotavirus Infections/*prevention & control ; Rotavirus Vaccines/Rotavirus Vaccines/Rotavirus Vaccines/*therapeutic use

  • Source: Scientific reports [Sci Rep] 2015 Oct 06; Vol. 5, pp. 14658. Date of Electronic Publication: 2015 Oct 06.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  15 نتائج ل ""Clinical Trials, Phase III as Topic""